Patent details

Basic Information

Publication number:

EP3119810

PCT Application Number:

US2015020564

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP157122417

PCT Publication Number:

WO2015142668

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR REDUCING CARDIOVASCULAR RISK

French Title of Invention:

MÉTHODE POUR LA RÉDUCTION DE RISQUE CARDIOVASCULAIRE

German Title of Invention:

METHODEN ZUR VERMINDERUNG VON KARDIOVASKULÄREM RISIKO

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

27/03/2024

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

02/05/2024

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

28/02/2024

Unitary Effect Registration Date:

02/05/2024

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

13/03/2015

Grant date:

28/02/2024

EP Publication Date:

25/01/2017

PCT Publication Date:

24/09/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/02/2024

EP B1 Publication Date:

28/02/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/03/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/05/2024

 

 

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Name:

Sanofi Biotechnology

Address:

82 Avenue Raspail, 94250 Gentilly, France (FR)

History of Owners

From:

21/02/2024

To:

24/05/2024

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Name:

Sanofi Biotechnology

Address:

54 rue La Boétie, 75008 Paris, France (FR)

Inventor

1

Name:

STEG, Philippe Gabriel

Address:

France (FR)

2

Name:

SASIELA, William, J.

Address:

United States (US)

3

Name:

PORDY, Robert, C.

Address:

United States (US)

4

Name:

BESSAC, Laurence

Address:

France (FR)

5

Name:

HANOTIN, Corinne

Address:

France (FR)

6

Name:

SCHWARTZ, Gregory, G.

Address:

United States (US)

Priority

1

Priority Number:

201461954094 P

Priority Date:

17/03/2014

Priority Country:

United States (US)

2

Priority Number:

201462025400 P

Priority Date:

16/07/2014

Priority Country:

United States (US)

3

Priority Number:

201462043182 P

Priority Date:

28/08/2014

Priority Country:

United States (US)

4

Priority Number:

15305293

Priority Date:

26/02/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 16/40; A61K 39/395; A61P 9/00;

Publication

European Patent Bulletin

1

Issue number:

202409

Publication date:

28/02/2024

Description:

Grant (B1)

2

Issue number:

202414

Publication date:

03/04/2024

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202426

Publication date:

26/06/2024

Description:

Change of owner's name or address

4

Issue number:

202418

Publication date:

01/05/2024

Description:

Unitary Effect Request Receipt

5

Issue number:

202422

Publication date:

29/05/2024

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages